Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Aravive Cash and Short Term Investments (Quarterly): 8.535M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 8.535M |
| June 30, 2023 | 18.36M |
| March 31, 2023 | 35.92M |
| December 31, 2022 | 53.69M |
| September 30, 2022 | 27.90M |
| June 30, 2022 | 46.83M |
| March 31, 2022 | 65.82M |
| December 31, 2021 | 59.42M |
| September 30, 2021 | 67.51M |
| June 30, 2021 | 75.44M |
| March 31, 2021 | 78.68M |
| December 31, 2020 | 60.54M |
| September 30, 2020 | 53.97M |
| June 30, 2020 | 60.06M |
| March 31, 2020 | 60.70M |
| December 31, 2019 | 65.13M |
| September 30, 2019 | 44.98M |
| June 30, 2019 | 48.38M |
| March 31, 2019 | 55.59M |
| December 31, 2018 | 56.99M |
| Date | Value |
|---|---|
| September 30, 2018 | 62.60M |
| June 30, 2018 | 67.78M |
| March 31, 2018 | 74.69M |
| December 31, 2017 | 81.15M |
| September 30, 2017 | 118.78M |
| June 30, 2017 | 143.36M |
| March 31, 2017 | 165.08M |
| December 31, 2016 | 201.15M |
| September 30, 2016 | 160.43M |
| June 30, 2016 | 137.50M |
| March 31, 2016 | 160.93M |
| December 31, 2015 | 182.07M |
| September 30, 2015 | 198.01M |
| June 30, 2015 | 214.67M |
| March 31, 2015 | 230.26M |
| December 31, 2014 | 170.57M |
| September 30, 2014 | 181.58M |
| June 30, 2014 | 192.77M |
| March 31, 2014 | 204.92M |
| December 31, 2013 | 13.29M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.535M
Minimum
Sep 2023
78.68M
Maximum
Mar 2021
51.77M
Average
56.70M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Esperion Therapeutics Inc | 82.25M |
| Processa Pharmaceuticals Inc | 4.706M |
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |